Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 6 Results

Intervention Indication Therapeutic Area Year Actions
Valoctocogene Roxaparvovec for Severe Haemophilia A Valoctocogene Roxaparvovec (BMN 270) Haemophilia A Haematology 2020 View  |  Download
Marstacimab for the treatment of haemophilia A and haemophilia B Marstacimab (PF-06741086) Haemophilia A , Haemophilia B Haematology 2023 View  |  Download
Giroctocogene fitelparvovec for haemophilia A Giroctocogene fitelparvovec Haemophilia A Haematology 2023 View  |  Download
Emicizumab for mild or moderate haemophilia A Emicizumab (Hemlibra) Haemophilia A Haematology 2021 View  |  Download
Efanesoctocog alfa for treating and preventing bleeding in people with haemophilia A who have been previously treated Efanesoctocog alfa Haemophilia A Haematology 2022 View  |  Download
Concizumab for treating haemophilia A and haemophilia B Concizumab (NN-7415; mAb-2021; NNC-0172-0000-2021; NNC-0172-2021; NNC-172-2021) Haemophilia A , Haemophilia B Haematology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications